Hostname: page-component-745bb68f8f-cphqk Total loading time: 0 Render date: 2025-02-06T08:58:37.127Z Has data issue: false hasContentIssue false

The role of illicit drug use in sudden death in the young

Published online by Cambridge University Press:  13 January 2017

Peter Fischbach*
Affiliation:
Children’s Pediatric Cardiology Fellowship Program, Sibley Heart Center Cardiology and Emory University, Atlanta, Georgia, United States of America
*
Correspondence to: P. Fischbach, Chief Academic Officer, Children’s Pediatric Cardiology Fellowship Program, Sibley Heart Center Cardiology and Emory University, 1405 Clifton Road NE, Atlanta, GA 30322, United States of America. Tel: 404 256 2593; Fax: 678 547 1494; E-mail: fischbachp@kidsheart.com
Rights & Permissions [Opens in a new window]

Abstract

The recreational use of illicit drugs remains an enormous and growing problem throughout the United States of America and around the world. Cocaine is most frequently thought of when considering the cardiovascular toxicity of illicit drugs. The association of cocaine use with sudden death due to myocardial ischaemia and infarction is well recognised, and this risk appears to be amplified by concomitant cigarette smoking and alcohol consumption. Like cocaine, amphetamine and its derivatives lead to indirect stimulation of the autonomic nervous system through the release of norepinephrine, dopamine, and serotonin in nerve terminals of the central and autonomic nervous systems. However, amphetamine lacks the ion channel-blocking properties of cocaine. Also similar to cocaine, coronary artery spasm may be induced in individuals with or without atherosclerotic disease and may lead to myocardial infarction. With the movement across the United States of America to legalise marijuana, or cannabis, for medicinal and recreational purposes, it is important to consider its potential deleterious effects. Marijuana has long been thought to have very few adverse effects with the exception of long-term dependence. There are, however, scattered reports of acute adverse events up to and including sudden death. These appear to be due to myocardial infarction. In conclusion, the incidence of sudden death associated with the use of these drugs varies from rare in the case of marijuana use to not infrequent with some drugs such as cocaine. It is important for care providers to recognise the potential for drug abuse when caring for a sudden cardiac arrest survivor.

Type
Original Articles
Copyright
© Cambridge University Press 2017 

The recreational use of illicit drugs remains an enormous and growing problem throughout the United States of America and around the world. The use of these compounds carries a social and financial price through many avenues including increased utilisation of healthcare services. Illicit drugs may lead to chronic illnesses requiring therapy, and there is the ever-present risk for sudden catastrophic events, frequently due to cardiovascular origin.

As Figure 1 shows, the use of illicit drugs among high-school seniors in the United States of America is roughly 40%. This number has been stable over the last 20 years.Reference Johnston, Miech, O’Malley, Bachman and Schulenberg 1 Figure 2 breaks down the drug use by individual drugs. 2 Although marijuana continues to be the most frequently used drug, the use of stimulant medications rises significantly during the course of high school. Not shown on these graphs is the recent explosion of heroin use. This appears to be linked to the increased use of prescription pain medications.

Figure 1 Trends in annual prevalence of use of an illicit drug in grades 8, 10, and 12. Retrieved from http://www.monitoringthefuture.org

Figure 2 Illicit and prescription drugs of abuse amongst middle- and high-school children. From the National Institute on Drug Abuse and retrieved https://www.drugabuse.gov/publications/drugfacts/high-school-youth-trends

As a cardiovascular provider, it is important to recognise the potential mechanisms that can be responsible for health problems created by these drugs’ use. This short review will outline some of the negative cardiovascular effects of the more common illicit drugs and in particular the mechanisms leading to sudden cardiac death.

Cocaine

Cocaine is most frequently thought of when considering the cardiovascular toxicity of illicit drugs. The association of cocaine use with sudden death due to myocardial ischaemia and infarction is well recognised. The differential diagnosis of all young patients, and even in older patients with no history of ischaemic heart disease, presenting to an emergency room with chest pain usually includes cocaine use. Certainly any adolescent presenting with evidence for myocardial ischaemia needs a full evaluation for potential cocaine intoxication. In a review of all non-traumatic sudden deaths occurring in southwest Spain, 3.1% were found to involve cocaine use.Reference Lucena, Blanc and Jurado 3

Cocaine is still used clinically as a local anaesthetic agent because of its ability to inhibit local electrical nerve transmission via blockade of sodium channels. When delivered systemically, cocaine can have direct effects on myocardial conduction and can lead to an electrocardiographic pattern mimicking Brugada syndrome.Reference Littmann, Monroe and Svenson 4 Clinically relevant systemic concentrations of cocaine can also inhibit the KCNH2 channel,Reference Ferreira, Crumb, Carlton and Clarkson 5 leading to a prolongation in the QT interval.

Cocaine is rapidly absorbed through all mucous membranes. It can be inhaled, injected, or smoked. Cocaine’s acute cardiovascular toxicity is due to activation of the autonomic nervous system leading to a supply-and-demand mismatch for oxygen. Cocaine acts by inhibiting the reuptake of catecholamines at sympathetic nerve terminals, the stimulation of central sympathetic outflow, and increased sensitivity of adrenergic nerve terminals to noradrenalin.Reference Lange and Hillis 6 , Reference Vongpatanasin, Mansour, Chavoshan, Arbique and Victor 7 This increases myocardial contractility, heart rate, and blood pressure. All of these contribute to increased myocardial oxygen demand. At the same time, cocaine use leads to coronary vasoconstriction and thrombosis via complex mechanisms including the inhibition of nitric oxide synthesis, enhanced release of endothelin-1, increased release of fibrinogen and von Willebrand factor.Reference Hobbs, Moore, Penkala, Bolgiano and Lopez 8 Reference Mo, Singh, Arruda and Dunea 10 Laboratory studies have also shown that cocaine may decrease protein C and anti-thrombin 3 concentrations as well as increasing thromboxane production, all of which promote thrombotic coronary occlusion.Reference Mouhaffel, Madu, Satmary and Fraker 11 , Reference Togna, Tempesta, Togna, Dolci, Cebo and Caprino 12 This combination of actions can induce myocardial ischaemia and infarction even in individuals with no atherosclerotic disease.

Although individuals are at risk for a sudden catastrophic event with even a single use, chronic use has also been linked to cardiac pathological gross and ultrastructural changes and increased risk for sudden death. These include myocarditis, cardiac hypertrophy, dilated carding myopathy, and accelerated atherosclerotic disease.Reference Brickner, Willard, Eichhorn, Black and Grayburn 13 Reference Willens, Chakko and Kessler 16

Cocaine is frequently used in combination with alcohol and cigarette smoking. Both of these appear to potentiate the risk for cardiovascular events due to cocaine. With the concurrent consumption of ethanol and cocaine, cocaethylene is produced in the liver. Cocaethylene slows down cardiac conduction and delays repolarisation through inhibition of sodium and potassium channels.Reference Wilson, Henning, Suttheimer, Lavins, Balraj and Earl 17 , Reference Xu, Crumb and Clarkson 18 Cocaethylene also inhibits the re-uptake of dopamine in the synaptic terminal.Reference Jatlow, Hearn, Elsworth, Roth, Bradberry and Taylor 19 Cocaine and cigarettes in combination increase myocardial oxygen demand to a greater degree than the two do individually.Reference Moliterno, Willard and Lange 20 Cigarette smoking by itself is known to cause endothelial dysfunction and platelet aggregation, which augments cocaine’s effects.

Stimulants

Amphetamine is a drug isolated from the plant Ephedra sinica and causes central nervous system stimulation. This drug has been used in Chinese medicine for over 5000 years and is known as ma huang. It was also used commonly in the United States of America as a nasal decongestant, bronchodilator, in the treatment for narcolepsy, and in that for hyperactivity in children. Methamphetamine, or crystal meth, is an amphetamine derivative that is easy to produce and may be taken orally, intravenously, or inhaled. Dextroamphetamine is another amphetamine derivative frequently used to treat attention deficit hyperactivity disorder.

Like cocaine, amphetamine and its derivatives lead to indirect stimulation of the autonomic nervous system through the release of norepinephrine, dopamine, and serotonin in nerve terminals of the central and autonomic nervous systems. Amphetamine lacks the ion channel-blocking properties of cocaine. The activation of the sympathetic nervous system leads to tachycardia and vasoconstriction, with pharmacokinetics and pharmacodynamics varying widely between individuals. Similar to cocaine, coronary artery spasm may be induced in individuals with or without atherosclerotic disease and may lead to myocardial infarction.Reference Bashour 21 , Reference Derlet, Rice, Horowitz and Lord 22

3,4-methylenedioxymethamphetamine (MDMA) or ecstacy is also a synthetic derivative of amphetamines and is produced in pill format. MDMA was first introduced into medicine by Merck & Co. as an appetite suppressant and was also found to be effective in treating alcoholism and depression. It became a popular street drug in the 1970s and grew in use during the late 1980s and 1990s, when it became associated with raves. Like other stimulants, it results in sympathetic stimulation leading to an increase in blood pressure and heart rate. Its metabolites may also result in vasospasm and thrombosis leading to myocardial infarction, ventricular arrhythmias, and sudden death.Reference Schifano, Oyefeso and Corkery 23 Unique to MDMA, it may also activate the 5-HT2B serotonergic receptors leading to pulmonary artery hypertension and valvular heart disease, similar to that seen with the now-banned appetite suppressant fen-phen.Reference Setola, Hufeisen and Grande-Allen 24

Cannabinoids

With the movement across the United States of America to legalise marijuana, or cannabis, for medicinal and recreational purposes, it is important to consider its potential deleterious effects. Marijuana has long been thought to have very few adverse effects with the exception of long-term dependence. There are, however, scattered reports of acute adverse events up to and including sudden death. These appear to be due to myocardial infarction.Reference Casier, Vanduynhoven, Haine, Vrints and Jorens 25

Cannabis has a biphasic effect on the autonomic nervous system. At low or moderate doses it causes tachycardia and hypertension due to increased sympathetic output and parasympathetic withdrawal, whereas higher doses inhibit sympathetic outflow and increase parasympathetic activity leading to bradycardia and hypotension. Cannabinoids have been shown to have limited direct effects on cellular electrophysiology, including shortening of the action potential duration and effective refractory period.Reference Miller, Dhingra, Kanakis, Amat-y-Leon and Rosen 26 This may predispose to atrial tachyarrhythmias.Reference Fisher, Ghuran, Vadamalai and Antonios 27 Myocardial ischaemia from coronary vasospasm has also been reported.Reference Fisher, Ghuran, Vadamalai and Antonios 27 This would be counter to Willie Nelson’s thoughts that marijuana “can only kill you if a bail of it falls on you”. The adverse effects of marijuana also appear to be potentiated with concomitant use of cocaine, alcohol, or amphetamines .

Over the last decade, there has been increasing use of synthetic cannabinoids such as “K2” and “spice”. These are synthetic compounds that are sprayed onto dried shredded plant material to smoke, or sold in liquid form. They were originally marketed as a safe and legal alternative to marijuana. The effects have been described as “cannabis like”. One advantage of these drugs for the user is that they do not show up on routine toxicology screening, though pharmacologically they act by activating the same receptors as the natural cannabinoids. Similar to marijuana, there have been isolated cases of myocardial infarction in otherwise healthy young persons that appear to be related to synthetic marijuana use.Reference Mir, Obafemi, Young and Kane 28 The effects of synthetic marijuana may in fact be more profound, as they may be significantly more potent than naturally occurring marijuana. Synthetic marijuana has been declared a controlled substance by the Food and Drug Administration.

Heroin

Heroine is a semi-synthetic analogue of morphine and acts directly on the vasomotor centre of the brain, increasing parasympathetic and decreasing sympathetic activity. Additionally, it activates mast cells to release histamine. In combination, the haemodynamic results are bradycardia and hypotension. Although accidental deaths due to heroin use are usually due to respiratory depression, an increase in cardiac automaticity is also observed with frequent ectopic atrial and ventricular beats, atrial fibrillation, and possibly ventricular tachycardia/fibrillation.Reference Lipski, Stimmel and Donoso 29 Of note for heroin addicts in methadone treatment programmes, methadone has been associated with QT prolongation and ventricular arrhythmias. This, however, is thought to be a rare event.Reference Anchersen, Clausen, Gossop, Hansteen and Waal 30

Conclusion

The recreational use of illicit drugs remains a significant problem around the world. The incidence of sudden death associated with the use of these drugs varies from rare in the case of marijuana use to not infrequent with some drugs such as cocaine. With all illicit drugs, their use is associated with an increase in risk for sudden death above that of the general population. It is important for care providers to recognise the potential for drug abuse when caring for a sudden cardiac arrest survivor or an otherwise healthy individual presenting with chest pain and electrocardiographic abnormalities suggesting ischaemia.

Acknowledgements

None.

Financial Support

This research or review received no specific grant from any funding agency or from commercial or not-for-profit sectors.

Conflicts of Interest

None.

Ethical Standards

The authors assert that all referenced work contributing to this review complies with the ethical standards of biomedical or medicolegal investigation.

References

1. Johnston, LD, Miech, RA, O’Malley, PM, Bachman, JG, Schulenberg, JE. Use of ecstasy, heroin, synthetic marijuana, alcohol, cigarettes declined among US teens in 2015. University of Michigan News Service, Ann Arbor, MI, December 16, 2015. Retrieved 14 May 2016 from http://www.monitoringthefuture.org.Google Scholar
2. National Institute on Drug Abuse. High school and youth trends, 2014. Retrieved 14 May 2016 from https://www.drugabuse.gov/publications/drugfacts/high-school-youth-trends.Google Scholar
3. Lucena, J, Blanc, M, Jurado, C, et al. Cocaine-related sudden death: a prospective investigation in south-west Spain. Eur Heart J 2010; 31: 318329.CrossRefGoogle ScholarPubMed
4. Littmann, L, Monroe, MH, Svenson, RH. Brugada-type electrocardiographic pattern induced by cocaine. Mayo Clin Proc 2000; 75: 845849.CrossRefGoogle ScholarPubMed
5. Ferreira, S, Crumb, WJ Jr, Carlton, CG, Clarkson, CW. Effects of cocaine and its major metabolites on the HERG-encoded potassium channel. J Pharmacol Exp Ther 2001; 299: 220226.Google Scholar
6. Lange, RA, Hillis, LD. Cardiovascular complications of cocaine use. N Engl J Med 2001; 345: 351358.Google Scholar
7. Vongpatanasin, W, Mansour, Y, Chavoshan, B, Arbique, D, Victor, RG. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation 1999; 100: 497502.Google Scholar
8. Hobbs, WE, Moore, EE, Penkala, RA, Bolgiano, DD, Lopez, JA. Cocaine and specific cocaine metabolites induce von Willebrand factor release from endothelial cells in a tissue-specific manner. Arterioscler Thromb Vasc Biol 2013; 33: 12301237.CrossRefGoogle Scholar
9. Siegel, AJ, Mendelson, JH, Sholar, MB, et al. Effect of cocaine usage on C-reactive protein, von Willebrand factor, and fibrinogen. Am J Cardiol 2002; 89: 11331135.Google Scholar
10. Mo, W, Singh, AK, Arruda, JA, Dunea, G. Role of nitric oxide in cocaine-induced acute hypertension. Am J Hypertens 1998; 11: 708714.Google Scholar
11. Mouhaffel, AH, Madu, EC, Satmary, WA, Fraker, TD Jr. Cardiovascular complications of cocaine. Chest 1995; 107: 14261434.Google Scholar
12. Togna, G, Tempesta, E, Togna, AR, Dolci, N, Cebo, B, Caprino, L. Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment. Haemostasis 1985; 15: 100107.Google Scholar
13. Brickner, ME, Willard, JE, Eichhorn, EJ, Black, J, Grayburn, PA. Left ventricular hypertrophy associated with chronic cocaine abuse. Circulation 1991; 84: 11301135.Google Scholar
14. Kolodgie, FD, Virmani, R, Cornhill, JF, Herderick, EE, Malcom, GT, Mergner, WJ. Cocaine: an independent risk factor for aortic sudanophilia. A preliminary report. Atherosclerosis 1992; 97: 5362.CrossRefGoogle ScholarPubMed
15. Virmani, R, Robinowitz, M, Smialek, JE, Smyth, DF. Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am Heart J 1988; 115: 10681076.CrossRefGoogle ScholarPubMed
16. Willens, HJ, Chakko, SC, Kessler, KM. Cardiovascular manifestations of cocaine abuse. A case of recurrent dilated cardiomyopathy. Chest 1994; 106: 594600.Google Scholar
17. Wilson, LD, Henning, RJ, Suttheimer, C, Lavins, E, Balraj, E, Earl, S. Cocaethylene causes dose-dependent reductions in cardiac function in anesthetized dogs. J Cardiovasc Pharmacol 1995; 26: 965973.Google Scholar
18. Xu, YQ, Crumb, WJ Jr, Clarkson, CW. Cocaethylene, a metabolite of cocaine and ethanol, is a potent blocker of cardiac sodium channels. J Pharmacol Exp Ther 1994; 271: 319325.Google Scholar
19. Jatlow, P, Hearn, WL, Elsworth, JD, Roth, RH, Bradberry, CW, Taylor, JR. Cocaethylene inhibits uptake of dopamine and can reach high plasma concentrations following combined cocaine and ethanol use. NIDA Res Monogr 1990; 105: 572573.Google Scholar
20. Moliterno, DJ, Willard, JE, Lange, RA, et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med 1994; 330: 454459.Google Scholar
21. Bashour, TT. Acute myocardial infarction resulting from amphetamine abuse: a spasm-thrombus interplay? Am Heart J 1994; 128: 12371239.CrossRefGoogle ScholarPubMed
22. Derlet, RW, Rice, P, Horowitz, BZ, Lord, RV. Amphetamine toxicity: experience with 127 cases. J Emerg Med 1989; 7: 157161.Google Scholar
23. Schifano, F, Oyefeso, J, Corkery, J, et al. Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002. Hum Psychopharmacol 2003; 18: 519524.CrossRefGoogle ScholarPubMed
24. Setola, V, Hufeisen, SJ, Grande-Allen, KJ, et al. 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol 2003; 63: 12231229.Google Scholar
25. Casier, I, Vanduynhoven, P, Haine, S, Vrints, C, Jorens, PG. Is recent cannabis use associated with acute coronary syndromes? An illustrative case series. Acta Cardiol 2014; 69: 131136.Google Scholar
26. Miller, RH, Dhingra, RC, Kanakis, C Jr, Amat-y-Leon, F, Rosen, KM. The electrophysiological effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac conduction in man. Am Heart J 1977; 94: 740747.Google Scholar
27. Fisher, BAC, Ghuran, A, Vadamalai, V, Antonios, TF. Cardiovascular complications induced by cannabis smoking: a case report and review of the literature. Emerg Med J 2005; 22: 679680.CrossRefGoogle ScholarPubMed
28. Mir, A, Obafemi, A, Young, A, Kane, C. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics 2011; 128: e1622e1627.CrossRefGoogle ScholarPubMed
29. Lipski, J, Stimmel, B, Donoso, E. The effect of heroin and multiple drug abuse on the electrocardiogram. Am Heart J 1973; 86: 663668.CrossRefGoogle ScholarPubMed
30. Anchersen, K, Clausen, T, Gossop, M, Hansteen, V, Waal, H. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. Addiction 2009; 104: 993999.Google Scholar
Figure 0

Figure 1 Trends in annual prevalence of use of an illicit drug in grades 8, 10, and 12. Retrieved from http://www.monitoringthefuture.org

Figure 1

Figure 2 Illicit and prescription drugs of abuse amongst middle- and high-school children. From the National Institute on Drug Abuse and retrieved https://www.drugabuse.gov/publications/drugfacts/high-school-youth-trends